Company overview
Basic information
Company name
Baltijos medis, UAB
Company code
300049573
VAT code
LT100004012614
Registered address
Klaipėda, Saulės g. 19, LT-91273
Registration date
2004-08-24
Company age: 22 y. 2 mo.
Contact information
Edit data
Phone
Presented as an image – cannot be copied
Presented as an image – cannot be copied
Email
Presented as an image – cannot be copied
Presented as an image – cannot be copied
Website
None
Company manager
For registered members only
Log in
Indicators
Risk factors
Activity
Legal form
Private Limited Liability Company
NACE activity
Accounting, bookkeeping and auditing activities; tax consultancy
Ownership form
Private without foreign capital
UAB "Baltijos medis"
Company code: 300049573
Address: Klaipėda, Saulės g. 19, LT-91273
VAT code: LT100004012614
Description
This description was generated by artificial intelligence.
Baltijos medis, UAB (company code 300049573) is an operational private limited liability company registered in 2004. It is classified as a micro-sized private enterprise in the national private non-financial companies sector, with private ownership and governance described as CEO only. The company’s share capital is EUR 2.9K. Its main activity under EVRK code N.69.20.00 is accounting, bookkeeping and auditing activities; tax consultancy. The company is based in Klaipeda, Saules g. 19, LT-91273, Klaipeda city municipality, Klaipeda County. In 2025, the company generated EUR 70.5K in revenue and EUR 9.6K in net profit, with a profit margin of 13.6%. Revenue increased by 14.6% year on year, after EUR 61.5K in 2024 and EUR 67.2K in 2023. Equity stood at EUR 39.7K and total assets at EUR 45.0K in 2025, with an equity ratio of 88.4%. The company employed an average of 5 people in each reported year, and so far in 2026 the average monthly wage was EUR 1,113.02, up from EUR 1,034.13 in 2025 and EUR 1,025.66 in 2024.
Download a detailed company report
Make confident decisions with all the information about Baltijos medis, UAB. In one document, you will find full financial data, risk and potential assessment, and key Scoris insights.